Paper Details

  1. Home
  2. Paper Details

Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.

Author: BrotchieJonathan M, FoxSusan H, JohnstonTom H, van der MeijAnne

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study assessed the ability of famotidine to treat levodopa-induced dyskinesia and wearing off in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-macaque model of PD. Famotidine, at a dose of 3 mg/kg, enhanced the peak-dose anti-parkinsonian actions and extended total duration of action of a low dose of levodopa.
Paper Details　
Original Abstract of the Article :
Levodopa-induced motor complications, including dyskinesia and wearing off, are troublesome side effects of treatment and impair quality of life in Parkinson's disease (PD) patients. The use of nondopaminergic agents as adjuncts to levodopa are potential options for managing these problems. Here, we...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/mds.23069

データ提供：米国国立医学図書館（NLM）

Levodopa-Induced Dyskinesia in Parkinson's Disease: Searching for Solutions in the Shifting Sands

Parkinson's disease (PD) is a neurodegenerative disorder that affects movement. Levodopa, a common treatment for PD, can cause troublesome side effects such as dyskinesia. This research investigates the potential benefits of famotidine, a histamine H2 antagonist, in managing levodopa-induced dyskinesia in a monkey model of PD. The study found that famotidine, at specific doses, could enhance the anti-parkinsonian effects of levodopa, potentially extending its duration of action and reducing dyskinesia. This research is like searching for a stable path through shifting sand dunes; it seeks to find ways to manage the side effects of levodopa and improve the quality of life for individuals with PD.

Famotidine: A Potential Oasis in the Desert of Parkinson's Disease

The study's findings suggest that famotidine may offer a promising approach to managing levodopa-induced dyskinesia in PD. The drug's ability to enhance the anti-parkinsonian effects of levodopa and potentially extend its duration of action could significantly improve the lives of individuals with PD. It's like finding a water source in the midst of a harsh desert; a potential solution to a persistent challenge.

Navigating the Desert of Parkinson's Disease with Famotidine

While this research is promising, further investigation is needed to confirm the findings in human patients. It's important to consult with healthcare providers to discuss the potential benefits and risks of using famotidine in conjunction with levodopa. This careful approach is like navigating a vast desert; it requires a thoughtful assessment of risks and potential rewards.

Dr. Camel's Conclusion

This research offers hope for individuals with Parkinson's disease experiencing the debilitating effects of levodopa-induced dyskinesia. The potential benefits of famotidine in managing these side effects are encouraging, but further research is necessary to confirm its effectiveness in humans. It's like finding a promising trail in the desert; further exploration is needed to determine its true value and potential for improving the lives of those with PD.

Date :
  1. Date Completed 2010-12-02
  2. Date Revised 2022-05-23
Further Info :

Pubmed ID

20310030

DOI: Digital Object Identifier

10.1002/mds.23069

Related Literature

Article Analysis
・Side Effects of famotidine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.